Details werden geladen...
Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition | The Manila Times
- Continued advancement of the ongoing Phase 1 study of RT-114 via RaniPill® for the treatment of obesity in collaboration with ProGen -
Ähnliche Seiten
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | The Manila Times
https://www.manilatimes.net/2026/05/12/tmt-newswire/globenewswire/tenax-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update/2341592Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | The Manila Times
https://www.manilatimes.net/2026/05/12/tmt-newswire/globenewswire/prelude-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update/2341598Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | The Manila Times
https://www.manilatimes.net/2026/05/15/tmt-newswire/globenewswire/indaptus-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update/2344835Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update | The Manila Times
https://www.manilatimes.net/2026/03/27/tmt-newswire/globenewswire/rani-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-provides-corporate-update/2308835Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/04/30/tmt-newswire/globenewswire/cartesian-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update/2332597